[1] ANDERSSON D I, HUGHES D.Antibiotic resistance and its cost:Is it possible to reverse resistance?[J]. Nature Reviews Microbiology, 2010, 8(4):260-271. [2] ROBERTS M C, STEFAN S, AARTS H J M.Acquired antibiotic resistance genes:An overview[J]. Frontiers in Microbiology, 2011, 2(203):1-27. [3] 胡燕, 白继庚, 胡先明, 等.我国抗生素滥用现状, 原因及对策探讨[J]. 中国社会医学杂志, 2013, 30(2):128-130. HU Y, BAI J G, HU X M, et al. Exploring on the status, reasons and countermeasures of antibiotic abuse[J]. Chinese Journal of Social Medicine, 2013, 30(2):128-130.(in Chinese) [4] HOUSTON D M.The use and misuse of antibiotics leading to increasing bacterial resistance and "Antibiotic Choice Frustration"[J]. Advances in Small Animal Medicine & Surgery, 2011, 24(7):1-2. [5] SCHLEMMER P B.Control of bacterial resistance and proper use of antibiotics in human health:Have we done enough?[J]. Bulletin de l'Académie Vétérinaire de France, 2012, 165(2):109-112. [6] BASSETTI M, POULAKOU G, RUPPE E, et al. Antimicrobial resistance in the next 30 years, humankind, bugs and drugs:Avisionary approach[J]. Intensive Care Medicine, 2017, 43(10):1464-1475. [7] JOHNSEN P J, TOWNSEND J P, BØHN T, et al. Factors affecting the reversal of antimicrobial-drug resistance[J]. Lancet Infectious Diseases, 2009, 9(6):357-364. [8] 蒋蓉, 刘冲, 张文婷, 等.耐药弯曲杆菌适应性代价研究进展[J]. 畜牧与兽医, 2010, 42(5):99-102. JIANG R, LIU C, ZHANG W T, et al. Research progress on the adaptive cost of resistant Campylobacter[J]. Animal Husbandry & Veterinary Medicine, 2010, 42(5):99-102.(in Chinese) [9] 吴春阳, 钱雪峰, 张险峰, 等.多重耐药鲍曼不动杆菌外排泵基因和外膜蛋白基因的检测[J]. 临床检验杂志, 2013, 31(7):531-534. WU C Y, QIAN X F, ZHANG X F, et al. Determination of efflux pump and outer membrane protein genes in multi-drug resistant Acinetobacter baumannii[J]. China Journal of Clinical Laboratory Science, 2013, 31(7):531-534.(in Chinese) [10] DEININGER K N, HORIKAWA A, KITKO R D, et al. A requirement of TolC and MDR efflux pumps for acid adaptation and GadAB induction in Escherichia coli[J]. The Public Library of Science One, 2011, 6(4):18960-18966. [11] 杨君宁.大肠埃希氏菌To1C与OmpF、OmpC及其双调节系统相互关系的研究[D].广州:中山大学, 2010. YANG J N.Study on the relationship between To1C, OmpF, OmpC of Escherichia coli and its dual regulation system[D].Guangzhou:Sun Yat-sen University, 2010.(in Chinese) [12] 姜兴粲, 李冰, 王玮玮, 等.中国药典中5种标准菌生长曲线的测定[J]. 浙江农业科学, 2020, 61(1):40-42. JIANG X C, LI B, WANG W W, et al. Determination of growth curve of 5 standard bacteria in Chinese Pharmacopoeia[J]. Zhejiang Agricultural Sciences, 2020, 61(1):40-42.(in Chinese) [13] SHANG W L, HU Q W, YUAN W C, et al. Comparative fitness and determinants for the characteristic drug resistance of ST239-MRSA-III-t030 and ST239-MRSA-III-t037 strains isolated in China[J]. Microbial Drug Resistance, 2016, 22(3):185-192. [14] 吴少鹏, 王国华, 赵效南, 等.山东省某地区奶牛源大肠埃希菌的血清型、耐药特性及分子特性[J]. 微生物学报, 2020, 60(3):486-498. WU S P, WANG G H, ZHAO X N, et al. Serotyping, drug resistance and molecular characteristics of Escherichia coli from dairy cows in a region of Shandong province[J]. Acta Microbiologica Sinica, 2020, 60(3):486-498.(in Chinese) [15] 张泽辉.辽宁地区奶牛乳房炎源大肠杆菌毒力与耐药相关性研究[D].沈阳:沈阳农业大学, 2017. ZHANG Z H.Study on correlation of virulence and restance of Escherichia coli isolated form day cows with mastitis in Liaoning province[D].Shenyang:Shenyang Agricultural University, 2017.(in Chinese) [16] 甘露, 李耘, 桥本重阳, 等.大肠埃希菌对碳青霉烯类抗生素的耐药机制研究[J]. 中国临床药理学杂志, 2020, 36(18):2896-2900. GAN L, LI Y, HASHIMOTO S, et al. Resistance mechanism of Escherichia coli to carbapenems[J]. Chinese Journal of Clinical Pharmacology, 2020, 36(18):2896-2900.(in Chinese) [17] 张立平, 张忠, 曾瑾, 等.宁夏地区162株大肠杆菌临床分离株对四环素类药物的耐药性分析[J]. 广东医学, 2013, 34(23):3580-3583. ZHANG L P, ZHANG Z, ZENG J, et al. Analysis of resistance to tetracyclines of 162 clinical isolates of Escherichia coli in Ningxia[J]. Guangdong Medical Journal, 2013, 34(23):3580-3583.(in Chinese) [18] 寇宏, 吕世明, 谭艾娟, 等.贵州省猪源大肠杆菌对磺胺类抗菌药物耐药性及耐药基因检测[J]. 中国兽医杂志, 2018, 54(9):75-78. KOU H, LYU S M, TAN A J, et al. Detecting antibiotic resistance and resistance genes of sulfonamides in Escherichia coli isolated from swine farms in Guizhou province[J]. Chinese Journal of Veterinary Medicine, 2018, 54(9):75-78.(in Chinese) [19] 王学君.贵州省猪源大肠杆菌四环素耐药水平和耐药基因相关性研究[D].贵阳:贵州大学, 2018. WANG X J.Study on the tetracycline resistance level of pig-derived Escherichia coli and the correlation between resistance genes[D].Guiyang:Guizhou University, 2018.(in Chinese) [20] 吴聪明, 沈建忠.动物源细菌耐药:现状、问题与对策[J]. 中华预防医学杂志, 2018, 52(4):340-343. WU C M, SHEN J Z.Antibiotic resistance of animal-derived bacteria:Current situation, problems and countermeasures[J]. Chinese Journal of Preventive Medicine, 2018, 52(4):340-343.(in Chinese) [21] ERIKA M C D, MAGAL P, OLIVIER D, et al. Modeling antibiotic resistance in hospitals:The impact of minimizing treatment duration[J]. Journal of Theoretical Biology, 2007, 249(3):487-499. [22] 于路妹.控制细菌耐药性发展与抗生素的合理使用[J]. 医学信息, 2013, 26(4):48-54. YU L M.Controlling the development of bacterial resistance and rational use of antibiotics[J]. Medical Information, 2013, 26(4):48-54.(in Chinese) [23] 何建明.植物来源的新抗菌药物和耐药调节剂[J]. 国外医药抗生素分册, 2015, 36(4):162-166. HE J M.New antibiotics and drug resistance regulators from plants[J]. World Notes on Antibiotics, 2015, 36(4):162-166.(in Chinese) [24] 姜力, 文学忠, 任清丹.细菌感染难以控制的原因及对策[J]. 吉林畜牧兽医, 2013, 34(2):14-16. JIANG L, WEN X Z, REN Q D.Reasons and countermeasures of bacterial infection difficult to control[J]. Jilin Animal Husbandry and Veterinary Medicine, 2013, 34(2):14-16.(in Chinese) [25] 肖永红.创新感染防控手段, 应对细菌耐药挑战[J]. 中华临床感染病杂志, 2011, 4(3):129-130. XIAO Y H.Innovation of infection prevention and control measures to meet the challenge of bacterial resistance[J]. Chinese Journal of Clinical Infectious Diseases, 2011, 4(3):129-130.(in Chinese) [26] 黄孝天, 刘晶星.抗肠球菌感染免疫治疗策略的基础理论[J]. 国外医学(预防诊断治疗用生物制品分册), 2005, 28(6):30-32. HUANG X T, LIU J X.Basic theory of immunotherapy strategy against enterococcal infection[J]. International Journal of Biologicals, 2005, 28(6):30-32.(in Chinese) [27] WORLD HEALTH ORGANIZATION.The evolving threat of antimicrobial resistance:Options for action[M].World Health Organization, 2012. [28] 杨焰, 游雪甫, 李聪然.耐药细菌的适应性代价及补偿性进化[J]. 中国抗生素杂志, 2019, 44(7):784-792. YANG Y, YOU X F, LI C R.The fitness cost and compensatory evolution of drug-resistant bacteria[J]. Chinese Journal of Antibiotics, 2019, 44(7):784-792.(in Chinese) [29] 孙硕, 吕世明, 谭艾娟, 等.适应度代价对大肠杆菌药物敏感性恢复的作用[J]. 天津农业科学, 2016, 22(4):33-35. SUN S, LYU S M, TAN A J, et al. Effect of the fitness cost on drug-resistanc reversal of Escherichia coli[J]. Tianjin Agricultural Sciences, 2016, 22(4):33-35.(in Chinese) [30] MICHAEL K, ANDERSSON D I.Amelioration of the fitness costs of antibiotic resistance due to reduced outer membrane permeability by upregulation of alternative porins[J]. Molecular Biology & Evolution, 2015, 32(12):3252-3263. [31] 戎建荣, 王淑峰, ALISON S, 等.外膜孔道蛋白ompC、ompF的表达与大肠埃希菌耐药的相关性研究[J]. 中华医院感染学杂志, 2009, 19(6):621-624. RONG J R, WANG S F, ALISON S, et al. Relationship between porins ompC and ompF and antibiotic resistance in Escherichia coli[J]. Chinese Journal of Nosocomiology, 2009, 19(6):621-624.(in Chinese) |